Medscape

Class I Recall of GE Healthcare TruSignal SpO2 Sensors

GE HealthCare is recalling 7559 TruSignal arterial oxygen saturation (SpO2) sensors because of problems that may reduce defibrillation energy, expose patients to unintended voltage, or give inaccurate ...
Nasdaq

GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency

SIGNA Sprint with Freelium, a new 1.5T sealed magnet MRI system, combines a sustainable design with uncompromised image quality, and operational autonomy to expand access to advanced MR, even in ...
Nasdaq

GE Healthcare (GEHC) Enters Partnership to Boost MRI Technology

GE Healthcare Technologies, Inc. GEHC, in collaboration with the University of Cincinnati (UC), UC Health, and Cincinnati Children’s, has announced a cutting-edge initiative to accelerate MRI ...
The Globe and Mail

GE Healthcare Advances TruSignal Pediatric SpO2 Study: What Investors Should Watch

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-conviction stock picks and new investing ...
Business Wire

GE HealthCare unveils next-generation SIGNA MRI technology, aiming to boost efficiency, enhance patient experience, and advance sustainability

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the 510(k) submissions to the U.S. Food and Drug Administration (FDA) seeking clearance for next-generation SIGNA™ MRI technology ...